A prospective study of the effect of diltiazem in renal allograft recipients receiving cyclosporine A: preliminary results
Kelly, J.J.; Walker, R.G.; d'Apice, A.J.; Kincaid-Smith, P.
Transplantation Proceedings 22(5): 2127-2128
1990
ISSN/ISBN: 0041-1345 PMID: 2219318 Document Number: 348121
Document emailed within 1 workday
Related Documents
MacDonald, A.S.; Daloze, P.; Dandavino, R.; Jindal, S.; Bear, L.; Dossetor, J.B.; Klassen, J.; Stiller, C.R.; Lockwood, B.; Reeve, C.E. 1987: A randomized study of cyclosporine with and without prednisone in renal allograft recipients. Canadian Transplant Group Transplantation Proceedings 19(1 Part 3): 1865-1866Smith, C.L.; Hampton, E.M.; Pederson, J.A.; Pennington, L.R.; Bourne, D.W. 1994: Clinical and medicoeconomic impact of the cyclosporine-diltiazem interaction in renal transplant recipients PharmacoTherapy 14(4): 471-481
Carpenter, C.B.; Milford, E.L.; Kirkman, R.L.; Strom, T.B.; Lazarus, J.M.; Tilney, N.L. 1985: Stability of renal allograft recipients after conversion from cyclosporine to azathioprine Transplantation Proceedings 17(4 Suppl 1: 261-265
Ingsathit, A.; Sumethkul, V.; Chalermsanyakorn, P.; Jirasiritham, S. 2006: Co-administration of diltiazem and cyclosporine for kidney transplant recipients: a four year follow-up study Journal of the Medical Association of Thailand 89(Suppl 2): S235-S241
Sadek, S.; Medina, Jé.; Arias, M.; Sennesael, J.; Squifflet, J-Paul.; Vogt, B. 2002: Short-term combination of mycophenolate mofetil with cyclosporine as a therapeutic option for renal transplant recipients: A prospective, multicenter, randomized study Transplantation 74(4): 511-517
O'Connell, P.; d'Apice, A.; Walker, R.; Francis, D.; Kincaid-Smith, P. 1988: Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone Transplantation Proceedings 20(1): 11-13
Gruber, S.A.; Skjei, K.L.; Sothern, R.B.; Robison, L.; Tzardis, P.; Moss, A.; Gillingham, K.; Canafax, D.M.; Matas, A.J.; Dunn, D.L. 1991: Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression Transplantation Proceedings 23(1 Pt 2): 1104-1105
Vilardell, J.; Oppenheimer, F.; Talbot-Wright, R.; Ricart, M.J.; Andreu, J.; Alcaraz, A.; Carretero, P. 1992: Increased risk of malignant tumors in renal transplant recipients receiving cyclosporine Transplantation Proceedings 24(5): 1948
Kahan, B.D.; Kramer, W.G.; Williams, C.; Wideman, C.A. 1986: Application of Bayesian forecasting to predict appropriate cyclosporine dosing regimens for renal allograft recipients Transplantation Proceedings 18(6 Suppl 5: 200-203
Sheil, A.G.; Disney, A.P.; Mathew, T.H.; Amiss, N.; Excell, L. 1991: Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA Transplantation Proceedings 23(1 Part 2): 1111-1112
Buturović, J.; Kandus, A.; Malovrh, M.; Bren, A.; Drinovec, J. 1990: Cyclosporine-associated hemolytic uremic syndrome in four renal allograft recipients: resolution without specific therapy Transplantation Proceedings 22(4): 1726-1727
Carrier, M.; Pelletier, G.B.; White, M.; Bois, D.; Pelletier, L.C. 1994: Effect of pentoxifylline on renal toxicity of cyclosporine: preliminary results Transplantation Proceedings 26(5): 2745-2746
Bunnag, S.; Vareesangthip, K.; Ong-ajyooth, L. 2006: Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine a in renal transplantation Journal of the Medical Association of Thailand 89(Suppl 2): S228-S234
Sonoda, K.; Meek, A.G.; Strober, S.; Hayashi, R.; Ishimaru, M.; Rapaport, F.T. 1989: Synergistic efficacy of staged total lymphoid irradiation and cyclosporine in the preoperative preparation of high-risk hyperimmunized canine renal allograft recipients Transplantation Proceedings 21(1 Pt 1): 1116-1117
Brynger, H.; Persson, H.; Flatmark, A.; Albrechtsen, D.; Frödin, L.; Tufvesson, G.; Gäbel, H.; Weibull, H.; Möller, E.; Lundgren, G. 1988: No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience Transplantation Proceedings 20(3 Suppl 3: 261-263
Durlik, M.; Gaciong, Z.; Soluch, L.; Rowińska, D.; Kozłowska-Boszko, B.; Rowiński, W.; Szmidt, J.; Lao, M. 1996: Results of kidney transplantation in HBsAG and anti-HCV seropositive renal allograft recipients Transplantation Proceedings 28(6): 3459-3460
Yoshimura, N.; Kahan, B.D.; Oka, T. 1991: The in vivo effect of cyclosporine on interleukin-6 gene expression in renal transplant recipients Transplantation Proceedings 23(1 Pt 2): 958-960
Lundgren, G.; Albrechtsen, D.; Brynger, H.; Flatmark, A.; Frödin, L.; Gäbel, H.; Lindholm, A.; Maurer, W.; Möller, E.; Persson, H. 1987: Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results Transplantation Proceedings 19(5): 3614-3618
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Vanrenterghem, Y.; Waer, M.; De Keyser, P.; Roels, L.; Michielsen, P. 1988: Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients Transplantation Proceedings 20(3 Suppl 3: 615-617